Browse Category

Analyst Ratings News 4 December 2025 - 5 December 2025

MercadoLibre (MELI) Stock on December 4, 2025: Bond Deal, New BTIG Price Target and Rising Short Interest – Does 30% Upside Still Hold?

MercadoLibre (MELI) Stock on December 4, 2025: Bond Deal, New BTIG Price Target and Rising Short Interest – Does 30% Upside Still Hold?

As of Thursday, December 4, 2025, MercadoLibre, Inc. (NASDAQ: MELI) is trading around $2,140 per share, leaving the Latin American e‑commerce and fintech giant roughly 19% below its 2025 all‑time high near $2,645 and comfortably above its 52‑week low around
Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher Corporation (NYSE: DHR) is back in the spotlight on December 4, 2025, as fresh bullish research, new institutional buying, and a high‑profile Morgan Stanley upgrade collide with a series of governance investigations into the company’s board. At the same
Lam Research (LRCX) Stock Today: AI Tailwinds, Analyst Upgrades and Valuation Warnings – Full December 4, 2025 Update

Lam Research (LRCX) Stock Today: AI Tailwinds, Analyst Upgrades and Valuation Warnings – Full December 4, 2025 Update

Lam Research Corporation (NASDAQ: LRCX) remains one of the most closely watched names in the semiconductor equipment space, as investors weigh a record AI‑driven upcycle against increasingly stretched valuations and fresh caution from some fundamental models. After closing at $159.75
Dayforce (NYSE: DAY) Stock on December 4, 2025: Thoma Bravo Buyout, Analyst Ratings and Latest Forecasts

Dayforce (NYSE: DAY) Stock on December 4, 2025: Thoma Bravo Buyout, Analyst Ratings and Latest Forecasts

Dayforce, Inc. (NYSE: DAY) stock is trading just below its agreed $70 per‑share cash buyout price from private‑equity firm Thoma Bravo, leaving a narrow merger‑arbitrage spread while investors weigh solid recurring‑revenue growth, mixed earnings, and a broadly “Hold” view from
Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast, Inc. (NYSE: TOST) is back in the market spotlight. As of early December 2025, the restaurant‑software specialist is trading in the mid‑$30s per share — around $35 — implying a market capitalization of roughly $20–21 billion and firmly placing
Marvell Technology (MRVL) Soars on Celestial AI Deal: Latest Earnings, Analyst Upgrades and 2026 Stock Forecast

Marvell Technology (MRVL) Soars on Celestial AI Deal: Latest Earnings, Analyst Upgrades and 2026 Stock Forecast

Updated: December 4, 2025 Marvell Technology, Inc. (NASDAQ: MRVL) is back in the market spotlight. The AI‑focused chip designer has just delivered record quarterly results, unveiled a $3.25 billion acquisition of photonics startup Celestial AI, and triggered a wave of
Capricor Therapeutics (CAPR) Soars After HOPE‑3 Win: Latest News, Analyst Targets and Stock Forecast as of December 4, 2025

Capricor Therapeutics (CAPR) Soars After HOPE‑3 Win: Latest News, Analyst Targets and Stock Forecast as of December 4, 2025

Updated: December 4, 2025 – mid‑day U.S. trading Capricor Therapeutics, Inc. (NASDAQ: CAPR) has just pulled off the kind of move small‑cap biotech traders dream about and risk managers lose sleep over. After releasing decisive Phase 3 data for its
1 19 20 21 22 23 33
Go toTop